Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > Annual report filed in US
View:
Comment by lscfa on Mar 07, 2022 5:13pm
  Qtr ending Vent patients Vent rev Other core rev Covid rev Total rev adj ebitda  ebitda margin Dec 21 8,405 21,888 7,059 3,015 ...more  
Comment by besttobe on Mar 07, 2022 5:26pm
Whatever.... Sameold...Stagnant revenue/decilning net income/headwinds and in limbo OIG report.. Yawn....nothing to get excited about here.  GLTA
Comment by LongTerm3 on Mar 07, 2022 5:29pm
LOL.   You have no idea how to read a financial statement. Lets see how the stock reacts tomorrow.
Comment by besttobe on Mar 07, 2022 5:43pm
The market has already reacted. New 52 week low today....and expect a new low tommorrow.  The hype on this stock is dead.  Short covered... GLTA
Comment by esifor on Mar 07, 2022 5:43pm
If we take COVID rev out of equation, then the YoY growth is 10.8% in dollars and 6.5% in patient count. The difference actually accounts for inflation fairly well. That means the real growth is 6.5%. Having a roughly 30% margin, they are slightly shy of rule of 40. I think the true future value of the company comes down to the change in that growth+margin over time. If they can operate ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities